Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Normalize Patient Conversations About HIV, ACOG Advises

Ob/gyns are uniquely positioned to help reduce disparities in HIV care.

Are Overinvolved Parents Delaying Young Adult Care?

Limited experience of young adults with healthcare and health decisions may increase risks for adult health issues.

Drinking While Pregnant On the Rise

The findings underscore the need for continued alcohol screening and counseling during prenatal care.

J&J Reaches Sweeping Talc Deal That Could End Decade Of Litigation

(This July 27 story has been republished, with no change to text)

US Judge Says Biden-era Restrictions on Prescribing Abortion Drug Are Unlawful

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe Preeclampsia Mapped in Affected Tissues in New Study

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

Todays Updates

Dupilumab Improves Allergic Fungal Rhinosinusitis Outcomes

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Fecal Transplant Raises Peanut Tolerance

Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.

Dupilumab Shows Long-Term Benefits in CRSwNP

Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.

Childhood Lupus: High Disease Activity Persists in Adulthood

Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.

First Dust Mite Immunotherapy Cleared for Scotland

Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.

Todays Updates

Dupilumab Improves Allergic Fungal Rhinosinusitis Outcomes

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Fecal Transplant Raises Peanut Tolerance

Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.

Dupilumab Shows Long-Term Benefits in CRSwNP

Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.

Childhood Lupus: High Disease Activity Persists in Adulthood

Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.

First Dust Mite Immunotherapy Cleared for Scotland

Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.

Latest News

Ob/gyns are uniquely positioned to help reduce disparities in HIV care.

Limited experience of young adults with healthcare and health decisions may increase risks for adult health issues.

The findings underscore the need for continued alcohol screening and counseling during prenatal care.

(This July 27 story has been republished, with no change to text)

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

News All Time

Risk Stratification for HR+/HER2- Early-Stage Breast Cancer: Insights Into Clinical and Genomic Risk Evaluations

Risk Stratification for HR+/HER2- Early-Stage Breast Cancer: Insights Into Clinical and Genomic Risk Evaluations

Why Does This Pregnant Woman Have Rectal Bleeding?

Getting a diagnosis was crucial, but options were limited for safe investigation

At-Home Transvaginal Ultrasound Feasible, Preferred by Some Patients

Trained remote sonographers guided patients through the process

Medicaid Funding Resumes for Planned Parenthood After Halting for Most of a Year

Some services are returning but others may not

Hospital Under Investigation; 4,000 Nurses Strike; Fentanyl Makers Pivot to Peptides

Health news and commentary gathered by MedPage Today staff

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients

"Most of the time we undertreat," says expert

They Told Families to 'Eat Real Food.' Now They May Cut the Produce Benefit.

To make America healthy, produce in a poor child's diet should be the last thing to go

ACOG Makes Vaccine Recommendations for the First Time

A look at how the recommendations differ from the CDC

Recommended News For You

For relapsed or resistant DLBCL, odronextamab produced positive results.

Cancer during young adulthood carries long-term mental toll, study finds

Breast cancer: A new target to eliminate dormant cells before they wake

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

Millions of men could benefit from faster scan to diagnose prostate cancer

Nasal therapeutic HPV vaccine could prevent cervical cancer

A study on lung cancer provides additional proof of the value of screening.

Recommended Articles For You

Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients 

Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

2.

PRO Data Strengthen Case for Dato-DXd in First-Line TNBC

3.

improvements in the treatment of prostate cancer resistant to chemotherapy.

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Canadian Group Calls for Earlier Colorectal Cancer Screening

1.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

2.

The Pros and Cons of Steroid Therapy for ITP

3.

The Risk Factors of Venous Thromboembolism and How to Lower Your Chances 

4.

Uncovering the Mystery of the Sessile Serrated Adenoma

5.

Understanding Sideroblastic Anemia and its Symptoms 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot